 |
|
|
| |
Potent and durable off-treatment reduction of HBsAg levels and cccDNA-derived transcripts by the CAM-E ALG-001075 in cellbased experiments
|
| |
| |
EASL 2026 May 26-3 Barcelona
Audrey Diederichs1,2, Maud Michelet1,2, Yannick Debing3, Jordi Verheyen3, Hannah Vanrusselt3, Julian Symons4, Tse-I Lin3,
Lawrence Blatt4, Fabien Zoulim1,2,5, Andreas Jekle4, Barbara Testoni1,2.
1Université Claude-Bernard Lyon 1, Inserm, UMR 1350 PaThLiv, Lyon, France; 2The Lyon Hepatology Institute, IHU EVEREST, Lyon, France; 3Aligos Belgium BV, Leuven, Belgium; 4Aligos Therapeutics, Inc., San Francisco, United States; 5Hepatology Department, Hospices Civils de Lyon, Lyon, France
|
| |
|
|
|
|
|
